Washington Post, May 23, 2013. Public health and consumer advocacy groups are attacking Senate legislation designed to tighten oversight of specialized pharmacies such as the one at the center of this past fall’s deadly meningitis outbreak, saying it does not adequately address health risks.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Poor Baby – Daddy’s Got a Text Message
The New York Times, March 29, 2013. When parents habitually dote on their phones or use their iPads to entertain their babies, they deny them the chance to engage with the three-dimensional world and connect to those in it.
Read More »U.S. Fraud Alert Warns of Doctors’ Ties to Medical Devices
March 27, 2013. The Office of the Inspector General has issued a special fraud alert, warning patients about doctors who also own businesses that sell medical devices that those physicians may then implant in their patients.
Read More »Maintaining Protection Against Superbugs
Washington Post, March 10, 2013. Senior Fellow Dr. Jennifer Yttri points out two areas where action can be taken to prevent the rise of antibiotic resistant bacteria.
Read More »FDA Advisors Vote Against Two Drugs for Menopausal Hot Flashes
Reuters, March 5, 2013. Advisers to the Food and Drug Administration on Monday voted against approval of two drugs designed to reduce the frequency and severity of hot flashes associated with menopause. “The FDA’s advisors did a great job today of carefully considering the scientific evidence,” said Diana Zuckerman, president of the National Research Center for Women & Families.
Read More »